Plenary Session 2 Psychometric Assessment. Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo
|
|
- Jordan Brown
- 5 years ago
- Views:
Transcription
1 Plenary Session 2 Psychometric Assessment Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo
2 Reliability Validity Group Discrimination, Sensitivity Validity Association with ADLs Validity Ability to Detect Clinically Meaningful Change
3 Cognitive Performance PRO Patient report Informant Report Composite MACFIMS CES-D-10 Depression Benedict RHB, et al (2004). Reliable Screening for Neuropsychological Impairment in MS. Multiple Sclerosis, 10:
4
5 100 MS Patient Volunteers from Community 100 NCs Most Sensitive Tests: Selective Reminding Test 7/24 Spatial Recall Test Paced Auditory Serial Addition Test Brief Repeatable Battery of Neuropsychological Tests for MS Selective Reminding Test 10/36 Spatial Recall Test Symbol Digit Modalities Test Paced Auditory Serial Addition Test Controlled Oral Word Association aka Verbal Fluency
6 % 22-31% % 12-19% 7-8% 13-19% 0 Language Spatial Abilities Attention Span Processing Speed Memory Executive Rao et al
7 Recommended Rao Battery: Problems No assessment of visual/spatial or executive function Psychometrics of adapted versions of SRT and 7/24 Spatial Recall Test unknown Validity of adapted version of SDMT unknown Lack of information on reliability: test-retest alternate form
8 SDMT test 1 vs test 2 r = 0.84 PASAT test1 vs test3 r = 0.70 Acceptable > 0.80 Costs of low reliability : - less confidence in accuracy in clinical settings - error variance reduces statistical power
9 Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach Benedict Fischer et al. Clinical Neuropsychologist, 2002 Standardized Manual, commercially available Normative Data Published, large sample, age Adequate Range Reliability Criterion Validity Alternate Forms Practical No ceiling or floor effects. Moderate/high test-retest reliability. Discriminates MS and controls, good sensitivity & specificity. Alternate forms are equivalent and reliable. Brief, minimal equipment, minimal confound of neurol signs.
10 Test Cognitive Domain Min Paced Auditory Serial Addition Test Processing Speed/Working Memory 10 Symbol Digit Modalities Test Processing Speed/Working Memory 5 California Verbal Learning Test Learning and Memory 25 Brief Visuospatial Memory Test Learning and Memory 10 D-KEFS Sorting Test Executive Function 25 Judgment of Line Orientation Test Visual-Spatial Ability 10 Controlled Oral Word Association Test Language and Other Domains 5 Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) Benedict et al, 2002
11 ns TestxTrial F=4.7 p<.05 T1 p<.001 T5 p=.05 Delay p<.01 p=.07 Trial F=49.7 p<.001 TestxTrial ns T1 ns T5 ns Delay ns
12
13 Test-Retest r CVLT2 Total Learning 0.78 CVLT2 Delayed Recall 0.89 BVMTR Total Learning 0.91 BVMTR Delayed Recall 0.85 PASAT Total Score 0.94 SDMT 0.97 COWAT 0.84
14 291 MS pts 56 controls Validity Visual Processing Speed and Memory Tests Most Sensitive in MS 59.5% impaired on 2 or more measures TEST % z< -1.5 COWAT 13.1 JLO 22.3 CVLT-II Learning 29.6 CVLT-II Delayed Recall 34.4 BVMT-R Learning 54.3 BVMT-R Delayed Recall 56.0 PASAT 3.0 ISI 27.4 PASAT 2.0 ISI 27.5 Symbol Digit Modalities Test 51.9 DKEFS Sorting Test Categories 15.8 DKEFS Sorting Test Description 25.8 Benedict RHB, et al (2006). J Inter Neuropsychol Soc 12:
15 % 22-31% % 12-19% 7-8% 13-19% 0 Language Spatial Abilities Attention Span Processing Speed Memory Executive Benedict et al MACFIMS data from 291 pts, superimposed on data adapted from Rao et al
16 Model Predicting disabled/employed status, conservatively defined (n=102) Odds* Ratio 95% Confidence Interval p Model Predicting disabled/employed status, liberally defined (n=162) Odds* Ratio 95% Confidence Interval p Depression Disease Course <0.001 CVLT2-DR BVMTR-DR ns ns PASAT ns SDMT ns ns DKEFS ns
17 Parmenter B, Testa SM, Schretlen DJ, Benedict RHB. (2010). Utility of Regressionbased Norms in Interpreting the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc, 16:6-16. Measure Predictor B Standard Error B T Standardized B Total R square SDMT (constant) age age sex education
18
19 Sample: 65 MS 46 NC 72% RR Mean EDSS = Memory Tests in Counterbalanced Order
20 Strober et al 2009: Comparing Effect Sizes Among Gold Standard Cognitive Outcomes
21 MACFIMS Rao BRNB 90 min testing 45 min testing Brief Assessment?? New Learning and Recall Memory Processing Speed and Working Memory Retention of Learned Material
22 Concurrent Validity SDMT most robust correlate with structural imaging MRI Partial r Bermel et al, 2003 BCR Benedict et al, VW Amato et al, 2004 Cortical Vol Christodoulou et al, 2004 Vent Vol Benedict et al, 2005 Temp Lobe Vol Benedict et al, 2006 BPF Benedict et al, VW Houtchens, Benedict, et al, 2007 Thalamic Vol Tekok-Kilic, Benedict, et al, 2007 R Sup Frnt GM Benedict, et al, 2009 Deep GM +0.62
23 Discriminative Validity - SDMT is most sensitive Camp et al. Brain. 1999;122: Benedict et al. JINS; 12: Benedict et al. Arch Neurol; 63: Deloire et al. JNNP. 2005;76: Deloire et al. MS. 2007;13:52-57 Huijbregts et al. Neurol. 2004; 63: Nocentini et al. MS. 2006;12:77-87 Parmenter et al. MS. 2007;13:52-57 Strober et al. MS. 2009; in press
24 SDMT in Longitudinal Work: Amato et al. Mult Scler, 2010
25 SDMT in Longitudinal Work: Amato et al. Mult Scler, 2010
26 Morrow SA, O Connor PW, Polman CH, Goodman AD, Kappos L, Lublin FD, Rudick RA, Jurgensen S, Paes D, Forrestal F, Panzara MA, Benedict RHB (2010). Evaluation of the Symbol Digit Modalities Test (SDMT) and MS Neuropsychological Screening Questionnaire (MSNQ) in Natalizumab treated MS patients over 48 weeks. Multiple Sclerosis, 16: pts, 109 sites in 21 countries Translated into 14 languages
27
28 Morrow SA, Jurgensen S, Forrestal, Munchauer FE, Benedict RHB. (2011). Effects of acute relapses on neuropsychological status in multiple sclerosis patients. Journal of Neurology, in press. 5% Drop 65 MS cases with confirmed relapses: age 42.9±7.8, 66.2% female, median EDSS 3.0 (range ). No significant difference on demographics or EDSS at baseline.
29 Adaptation of SDMT to the MSFC: Drake et al. Mult Scler, 2010
30 Symbol Digit Modalities Test in MSFC Test-Retest over 2 years MSFCPjnims r = 0.84; MSFCSjnims r = 0.83 MSFCPjninc r = 0.80; MSFCSjninc r = 0.81
31 BICAMS Brief International Cognitive Assessment for MS BICAMS Member Meeting September 11, 2010 Chairs: Dawn Langdon and Ralph Benedict 1. The committee will recommend a brief cognitive assessment that is optimised for small centres, with perhaps one or few staff members, who may not have neuropsychological training. 2. The recommended assessment will be constructed to maximise international use, although in the first instance suitability may only be established for certain areas of the world. 3. The committee will review relevant scientific papers and evaluate possible scales for psychometric qualities, international application, ease of administration, feasibility in the specified context and acceptability to patients. 4. A consensus opinion article will be submitted by the committee, which will comprise the objectives, a literature review, and recommendations
32 Language and Spatial Processing Controlled Oral Word Association Test Judgment of Line Orientation Test PSYCHOMETRIC AVE PRAGMATIC AVE Memory Wechsler Memory Scale Rey Auditory Verbal Learning Test California Verbal Learning Test Selective Reminding Test Brief Visuospatial Memory Test Revised 10/36 or 7/24 Spatial Recall Test PSYCHOMETRIC AVE PRAGMATIC AVE Attention, Processing Speed, Working Memory Digit Span Spatial Span Wechsler Digit Symbol or Coding Test Symbol Digit Modalities Test Paced Auditory Serial Addition Test Stroop Conflict Tasks N-Back Tasks PSYCHOMETRIC AVE PRAGMATIC AVE Higher Executive Function Wisconsin Card Sorting Test Tower Tasks, eg Tower of London DKEFS Sorting Test Raven's Progressive Matrices PSYCHOMETRIC AVE PRAGMATIC AVE
33 Table 1 Manner in which BICAMS measures meet psychometric criteria in samples with English as a first language. SDMT CVLT2 Learning BVMTR Learning Standardization Smith 1982 Teat Manual Delis 2000 Test Manual Benedict 1997 Test Manual Normalization Parmenter Peer review journal article Delis 2000 Test Manual Benedict 2005 Test Manual Reliability I: Test-Retest Benedict 2005 r = 0.91 Benedict 2005 r = 0.80 Benedict 2005 r = 0.91 Reliability II: Alternate Form Rao No or Little Data Delis Fair Benedict Good Validity I: Criterion Related Validity II: Clinically Meaningful Change Many Studies. Good Many Studies. Good Many Studies. Good Morrow Fair No or Little Data No or Little Data
34 Multiple Sclerosis (MS) CDE Working Group Chairman: [Ralph HB Benedict] Subgroup members: [Dawn Langdon, Lauren Krupp, Nicholas LaRocca, Steve Rao] Which psychometric tests should be recommended as a brief battery ie supplemental CDE for studies focusing on cognition in MS? Should any test be recommended for the overall core MS CDE?
35 Test Domain Time CVLT2 Learning Trials 1-5 auditory/verbal memory 10 min BVMTR Learning Trials 1-3 visual/spatial memory 05 min Rao PASAT 3.0 ISI Rao SDMT processing speed and working memory 05 min processing speed and working memory 05 min DKEFS Sorting Test executive function 10 min CVLT2 Delayed Recall auditory/verbal memory 10 min BVMTR Delayed Recall visual/spatial memory 05 min COWAT executive function 05 min
36 Symbol Digit Modalities Test (SDMT) recommended for MS CDE 1. Excellent reliability 2. Excellent discriminative validity 3. Can replace the PASAT in MSFC 4. Clinically meaningful change associated with discrete raw score decline
37
38
39
40 Conclusions Self Report is Invalid, performance measures are and will be needed SDMT is the most cost effective and sensitive test available Should be complemented by verbal and visual memory tests Psychometric standards will be increasingly emphasized in clinical trial work
Cognitive rehabilitation: assessment. Dawn Langdon PhD
Cognitive rehabilitation: assessment Dawn Langdon PhD 1 Assessment for cognitive rehabilitation Patient context Individual Family Work Insight Mood Motivation Observation of patient performance Rehabilitation
More informationPrevalence of Cognitive Impairment in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis
SHORT REPORT Prevalence of Cognitive Impairment in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis Giulia DiGiuseppe, BSc; Mervin Blair, PhD; Sarah A. Morrow, MD Background: Cognitive impairment
More informationAnxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS
ARTICLES This article addresses the Core Competency of Patient Care and Procedural Skills Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS Sarah
More informationCOGNITIVE AND BRAIN CHANGES IN MULTIPLE SCLEROSIS
1 COGNITIVE AND BRAIN CHANGES IN MULTIPLE SCLEROSIS MARCH 27, 2017 Esther Fujiwara, Ph.D. (efujiwara@ualberta.ca) Department of Psychiatry, University of Alberta 2 Objectives 1. Identify cognitive challenges
More informationThe Use of Brief Assessment Batteries in Multiple Sclerosis. History of Cognitive Studies in MS
This is the html version of the file http://wwwvagov/ms/library/managing/robert_kane_brief_assessment_batteries_in_msppt Google automatically generates html versions of documents as we crawl the web 1
More informationMariana López-Góngora 1,2,3*, Luis Querol 1,3 and Antonio Escartín 1,2,3
López-Góngora et al. BMC Neurology (2015) 15:40 DOI 10.1186/s12883-015-0296-2 RESEARCH ARTICLE Open Access A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial
More informationValidity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
690821MSJ0010.1177/1352458517690821Multiple Sclerosis JournalRHB Benedict, J DeLuca review-article2017 MULTIPLE SCLEROSIS JOURNAL MSJ Invited Review Validity of the Symbol Digit Modalities as a cognition
More informationA randomised, placebo-controlled trial investigating the role of Fampridine in cognitive performance of patients with multiple sclerosis.
A randomised, placebo-controlled trial investigating the role of Fampridine in cognitive performance of patients with multiple sclerosis. PRINCIPAL INVESTIGATOR: Name: Carlo Pozzilli Institution/Organization:
More informationImpairments in cognitive abilities are among the. Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis
Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis Heather Becker, PhD; Alexa Stuifbergen, PhD, RN, FAAN; Janet Morrison, MSN, RN Cognitive impairment has a major
More informationCognitive Impairment Among Patients with Multiple Sclerosis. Associations with Employment and Quality of Life.
Cognitive Impairment Among Patients with Multiple Sclerosis. Associations with Employment and Quality of Life. J Campbell 1, W Rashid 2, M Cercignani 1, D Langdon 3. 1 Clinical Imaging Sciences Centre,
More informationProcess of a neuropsychological assessment
Test selection Process of a neuropsychological assessment Gather information Review of information provided by referrer and if possible review of medical records Interview with client and his/her relative
More informationCognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background
Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis Victoria A Levasseur 1,2, Samantha Lancia 1, Gautam Adusumilli 1, Zach Goodman 1, Stuart D. Cook 3, Diego Cadavid 4, Robert T.
More informationTable 1: Summary of measures of cognitive fatigability operationalised in existing research.
Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Candidate Mmeasures Studies Procedure Self-reported fatigue measure Key Findings The auditory As and auditory
More informationMultiple sclerosis : how cognitive performance relates to quality of life, depression, and perception of deficits
Oregon Health & Science University OHSU Digital Commons Scholar Archive May 2011 Multiple sclerosis : how cognitive performance relates to quality of life, depression, and perception of deficits Rebecca
More informationOriginal Paper. Eur Neurol 2017;77: DOI: /
Original Paper Received: October 31, 2016 Accepted: February 21, 2017 Published online: March 21, 2017 Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection
More informationDetecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?
Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors? Jennifer Lewis, PsyD; Mathew Hirsch, PsyD & Susan Abramowitz, PhD NYU School of Medicine, New York, NY Friday,
More informationMultiple sclerosis (MS) is a neurologic disorder. The Perceived Deficits Questionnaire. Perception, Deficit, or Distress?
The Perceived Deficits Questionnaire Perception, Deficit, or Distress? Lauren B. Strober, PhD; Allison Binder, BS; Olga M. Nikelshpur, PhD; Nancy Chiaravalloti, PhD; John DeLuca, PhD Background: Cognitive
More informationReview Article Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features
Hindawi Behavioural Neurology Volume 2017, Article ID 1463570, 11 pages https://doi.org/10.1155/2017/1463570 Review Article Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic,
More informationM P---- Ph.D. Clinical Psychologist / Neuropsychologist
M------- P---- Ph.D. Clinical Psychologist / Neuropsychologist NEUROPSYCHOLOGICAL EVALUATION Name: Date of Birth: Date of Evaluation: 05-28-2015 Tests Administered: Wechsler Adult Intelligence Scale Fourth
More informationBrief International Cognitive Assessment for MS (BICAMS): international standards for validation
BMC Neurology This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Brief International Cognitive
More informationResearch Article Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
Hindawi Behavioural Neurology Volume 2017, Article ID 7404289, 10 pages https://doi.org/10.1155/2017/7404289 Research Article Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with
More informationSuicide Rate: Depression vs MS vs TM
Suicide Rate: Depression vs MS vs TM History and Epidemiology of Cognitive Impairment in MS Charcot (1877) noted that at a certain stage of the disease patients with MS may show marked enfeeblement of
More informationBrief International Cognitive Assessment for MS (BICAMS): international standards for validation
Benedict et al. BMC Neurology 2012, 12:55 ORIGINAL PAPER Open Access Brief International Cognitive Assessment for MS (BICAMS): international standards for validation Ralph HB Benedict *, Maria Pia Amato,
More informationCognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves
744 SHORT REPORT Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves A Achiron, M Polliack, S M Rao, Y Barak, M Lavie, N Appelboim, Y Harel... Background
More informationAD Prevention Trials: An Industry Perspective
AD Prevention Trials: An Industry Perspective Robert A. Lasser, MD, MBA Global Development Lead, Product Development Group Medical Director, Neurodegenerative Disorders F. Hoffmann - La Roche Ltd Regulatory
More informationBrain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis
Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationCognitive impairment is a prevalent concern in. Longitudinal Stability of Cognition in Early-Phase Relapsing-Remitting Multiple Sclerosis
Longitudinal Stability of Cognition in Early-Phase Relapsing-Remitting Multiple Sclerosis Does Cognitive Reserve Play a Role? Roxana M. Barbu, MCogSci; Jason A. Berard, BScH; Louise M. Gresham, BScH; Lisa
More informationUpdate and Review of Disease Protocols: Specifications for the Neuropsychological Evaluation of ADHD/ADD
Update and Review of Disease Protocols: Specifications for the Neuropsychological Evaluation of ADHD/ADD Chris M. Front, Psy.D., ABAP Office of Aerospace Medicine Washington, DC 5th Annual Aerospace Psychology
More informationValidation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis. E. Polychroniadou 1, C. Bakirtzis 1, D Langdon 2, R. Lagoudaki 3,
More informationAn Initial Validation of Virtual Human Administered Neuropsychological Assessments
Annual Review of Cybertherapy and Telemedicine 2017 123 An Initial Validation of Virtual Human Administered Neuropsychological Assessments Thomas D. PARSONS a,*, Paul SCHERMERHORN b, Timothy MCMAHAN a,
More informationPhysical Activity and Cognitive Function in Multiple Sclerosis
RESEARCH NOTE Journal of Sport & Exercise Psychology, 2011, 33, 734-741 2011 Human Kinetics, Inc. Physical Activity and Cognitive Function in Multiple Sclerosis Robert W. Motl, 1 Eduard Gappmaier, 2 Kathryn
More informationMeasurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History
Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History Group Means for NP and MMPI Variables N=381 Consecutive
More informationGoretti et al. BMC Neurology 2014, 14:171
Goretti et al. BMC Neurology 2014, 14:171 RESEARCH ARTICLE Open Access The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections
More informationAIMS M U L T I P L E S C L E R O S I S. Cognitive Issues in
Jointly provided by In collaboration with N PA w w w.c m e A I M S. o r g AIMS ADVANCES IN MULTIPLE SCLEROSIS Cognitive Issues in M U L T I P L E S C L E R O S I S A U T H O R S Ralph H. Benedict, PhD
More informationResearch Article Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
Behavioural Neurology, Article ID 637694, 5 pages http://dx.doi.org/1.1155/214/637694 Research Article Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple
More informationEffect of Boswellia papyrifera on cognitive impairment in multiple sclerosis
Iranian Journal of Neurology Original Paper Iran J Neurol 2014; 13(3): 149-153 Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis Received: 12 May 2014 Accepted: 15 Apr 2014 Behnaz
More informationCOGNITIVE REHABILITATION OF INDIVIDUALS WITH MS CMSC 2015
COGNITIVE REHABILITATION OF INDIVIDUALS WITH MS CMSC 2015 Aaron Turner, Ph.D. (ABPP-RP) Director, Rehabilitation Psychology VA Puget Sound Health Care System Associate Professor Department of Rehabilitation
More informationKorean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)
Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP) Yeonwook Kang, Ph.D. Department of Psychology, Hallym University Department of Neurology, Hallym University Sacred Heart
More informationResearch Article Does Fatigue Complaint Reflect Memory Impairment in Multiple Sclerosis?
Multiple Sclerosis International, Article ID 692468, 6 pages http://dx.doi.org/10.1155/2014/692468 Research Article Does Fatigue Complaint Reflect Memory Impairment in Multiple Sclerosis? Caroline Jougleux-Vie,
More informationExamining the Link between Information Processing Speed and Executive Functioning in Multiple Sclerosis
Archives of Clinical Neuropsychology 24 (2009) 47 58 Examining the Link between Information Processing Speed and Executive Functioning in Multiple Sclerosis Abstract Margaret A. Drew, Nicola J. Starkey*,
More informationMeniere s Disease Case. Suzanne Beason-Hazen, Ph.D.
Meniere s Disease Case Suzanne Beason-Hazen, Ph.D. IDENTIFYING INFORMATION 64-year-old man, 15 years of education (three years of college, did not complete a degree) Employed as airline transport pilot
More informationCognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao s Brief Repeatable Battery
Hansen et al. BMC Neurology (2015) 15:246 DOI 10.1186/s12883-015-0497-8 RESEARCH ARTICLE Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao
More informationThe Influence of Sleep on Cognition in Breast Cancer
The Influence of Sleep on Cognition in Breast Cancer Sonia Ancoli-Israel, PhD Professor of Psychiatry and Medicine University it of California i San Diego Fatigue by Rodin Supported by NIC CA112035, UL1RR031980
More informationMS Gait and Balance Symposium Summary 2014: The Role of Cognition. Michelle Cameron, Kathleen Zackowski. Disclosures
MS Gait and Balance Symposium Summary 2014: The Role of Cognition Michelle Cameron, Kathleen Zackowski Disclosures Dr. Cameron has received: Consulting fees and honoraria from Acorda Therapeutics, Genzyme
More informationInternational Symposium on. Barcelona, May 5 th and 6 th 2011
th International Symposium on Barcelona, May 5 th and 6 th 2011 4rd Symposium on Psychiatry and HIV --- Barcelona, May 6th 2010 Neurocognitive Testing in HIV Infection: How to Implement this Assessment
More informationIssues of Neuropsychological Assessment in International Settings
Issues of Neuropsychological Assessment in International Settings Kevin Robertson, Ph.D. Director of Neuropsychology, Neurology University of North Carolina at Chapel Hill Igor Grant, M.D. Director, HIV
More informationAPPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA
APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA The normative sample included 641 HIV-1 seronegative gay men drawn from the Multicenter AIDS Cohort Study (MACS). Subjects received a test battery consisting
More informationbattery assessing general cognitive functioning (Mini-Mental State Examination, MMSE),
SUPPLEMENTARY MATERIAL Neuropsychological battery Patients tested at the Rotman Research Institute were administered a neuropsychological battery assessing general cognitive functioning (Mini-Mental State
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea Supplemental Methods Participants From
More informationElderly Norms for the Hopkins Verbal Learning Test-Revised*
The Clinical Neuropsychologist -//-$., Vol., No., pp. - Swets & Zeitlinger Elderly Norms for the Hopkins Verbal Learning Test-Revised* Rodney D. Vanderploeg, John A. Schinka, Tatyana Jones, Brent J. Small,
More informationCRITICALLY APPRAISED PAPER
CRITICALLY APPRAISED PAPER Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013). Cognitive training for improving executive function in chemotherapy-treated
More informationInnovazione e personalizzazione nella terapia della SM. Rocco Totaro Centro per la Diagnosi e Cura delle Malattie Demielinizzanti L Aquila
Innovazione e personalizzazione nella terapia della SM Rocco Totaro Centro per la Diagnosi e Cura delle Malattie Demielinizzanti L Aquila Which are the objectives of MS treatment? «Historically»
More informationTrail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6
NEUROLOGY/2016/790584 Table e-1: Neuropsychological test battery Cognitive domain Test Attention/processing speed Digit symbol-coding 1 Trail making test A 2,3 Memory Logical memory Story A delayed recall
More informationCarmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation
Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation Neuropsychological Tests Battery The following List represents
More informationTeaching Course 5 IMSCOGS
Teaching Course 5 IMSCOGS NEDA controversy: cognition and fatigue are irrelevant for guiding treatment decisions as they are not measurable in an objective and time-saving fashion Chairs: F. Paul (Berlin,
More informationReliability and Validity of a Danish Version of the Multiple Sclerosis Neuropsychological Screening Questionnaire
CME/CNE ARTICLE 2018 SERIES NUMBER 1 Reliability and Validity of a Danish Version of the Multiple Sclerosis Neuropsychological Screening Questionnaire Tobias Sejbæk, MD; Morten Blaabjerg, MD, PhD; Pippi
More informationInternational Forum on HIV and Rehabilitation Research
Neurocognitive screening and behavioural interventions for HIV-Associated Neurocognitive Disorders (HAND) International Forum on HIV and Rehabilitation Research Translating Research Evidence from the Canada-UK
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-16-1-0693 TITLE: Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis PRINCIPAL INVESTIGATOR: Ellen Mowry, M.D., M.C.R. CONTRACTING ORGANIZATION: Johns Hopkins
More informationLongitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome
DOI 10.1007/s00415-014-7413-9 ORIGINAL COMMUNICATION Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome Tomas Uher Jana Blahova-Dusankova Dana Horakova Niels
More informationC ognitive problems are common in patients with
PAPER Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis N B Lincoln, A Dent, J Harding, N Weyman, C Nicholl, L D Blumhardt E D Playford... See end of article
More information21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist
Today s webinar will answer. 1. What is the RBANS, and how is the updated version different than the original version? 2. What are the neurocognitive areas assessed by the RBANS and what scores are available?
More informationResearch Article Impact of Depression, Fatigue, and Global Measure of Cortical Volume on Cognitive Impairment in Multiple Sclerosis
BioMed Research International Volume 2015, Article ID 519785, 7 pages http://dx.doi.org/10.1155/2015/519785 Research Article Impact of Depression, Fatigue, and Global Measure of Cortical Volume on Cognitive
More informationImproving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan
Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan Grant L. Iverson, Ph.D, Professor Department of Physical Medicine and Rehabilitation Harvard Medical School & Red Sox
More informationORIGINAL CONTRIBUTION. Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
ORIGINAL CONTRIBUTION Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Massimiliano Calabrese, MD; Federica Agosta, MD; Francesca Rinaldi, MD;
More informationCan aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators
Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators ASPREE Randomized, double-blind, placebo-controlled trial for extending healthy
More informationNEUROBEHAVIORAL EVALUATION OF HOUSEHOLD EXPOSURE TO DURSBAN 1
RAYMOND SINGER, PH.D. A Professional Association 444444444444444444444444444444444444444444444444444 36 Alondra Road / Santa Fe, New Mexico / 87508 Alternate office: 180 E. 79th Street / Suite 1-C / New
More informationAdaptive Design in CIAS
Adaptive Design in CIAS or If you don t know where you re going, any road will get you there Michael Sand, PhD, MPH Senior Clinical Program Leader, CNS Boehringer Ingelheim Disclosures I m an employee
More informationASHI 712. The Neuroscience of Human Memory. Dr. Olave E. Krigolson LECTURE 2: Short Term Memory and Sleep and Memory
ASHI 712 The Neuroscience of Human Memory Dr. Olave E. Krigolson krigolson@uvic.ca LECTURE 2: Short Term Memory and Sleep and Memory Working / Short Term Memory Sunglasses Chair Dress Earrings Boots Bed
More informationThe Relationship Between Age and Cognitive Function in HIV-Infected Men
The Relationship Between Age and Cognitive Function in HIV-Infected en Emily C. Kissel Nicole D. Pukay-artin, B.A. Robert A. Bornstein, Ph.D. Several studies have identified increased age as a risk factor
More informationMeta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives
SUPPLEMENTARY MATERIAL Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives B. Arts 1 *, N. Jabben 1, L. Krabbendam 1 and J. van Os 1,2 1 Department of Psychiatry
More informationMaryse Bouchard, PhD
Maryse Bouchard, PhD Researcher Research Center CHU Sainte-Justine University of Montreal Adjunct Professor, CINBIOSE, University of Quebec at Montréal Highest concentrations found in groundwater In the
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationSupplementary Online Content
Supplementary Online Content Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs non-opioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain:
More informationPsychotherapy in MS Patients with Dementia and Personality Changes
Psychotherapy in MS Patients with Dementia and Personality Changes Ralph HB Benedict, PhD Professor of Neurology University at Buffalo, State University of New York Research Support from the NIH, National
More informationREPORT OF NEUROPSYCHOLOGICAL ASSESSMENT
Gary G. Kay, Ph.D. Clinical Neuropsychologist WASHINGTON NEUROPSYCHOLOGICAL INSTITUTE, LLC 4900 MASSACHUSETTS AVE, NW SUITE 240 WASHINGTON, DC 20016 PH. 202-686-7520 FAX 202-686-8802 REPORT OF NEUROPSYCHOLOGICAL
More informationAge and disability drive cognitive impairment in multiple sclerosis across disease subtypes
674367MSJ0010.1177/1352458516674367Multiple Sclerosis JournalL Ruano, E Portaccio research-article2016 MULTIPLE SCLEROSIS JOURNAL MSJ Original Research Paper Age and disability drive cognitive impairment
More informationThe rs SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis
Pathophysiology 18 (2011) 43 52 The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis Bianca Weinstock-Guttman a, Ralph H.B.
More informationSupplementary Online Content
Supplementary Online Content Sun LS, Li G, Miller TLK, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. doi:10.1001/jama.2016.6967
More informationThe Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery
Ozakbas et al. BMC Neurology (2017) 17:208 DOI 10.1186/s12883-017-0993-0 RESEARCH ARTICLE The Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery
More informationValidation of an Internet-based Approach to Cognitive Screening in Multiple Sclerosis
Validation of an Internet-based Approach to Cognitive Screening in Multiple Sclerosis by Nadine Akbar A thesis submitted in conformity with the requirements for the degree of Master of Science Institute
More informationPersonality Disorder in Multiple Sclerosis Correlates With Cognitive Impairment
Personality Disorder in Multiple Sclerosis Correlates With Cognitive Impairment Ralph H.B. Benedict, Ph.D. Roger L. Priore, Sc.D. Colleen Miller, R.N., N.P., D.N.S. Frederick Munschauer, M.D. Lawrence
More informationThe Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis
Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects Summer 8-13-2016 The Use of Amphetamines for Improving Cognitive Impairment in Patients
More informationNIH Toolbox. Scoring and Interpretation Guide. September 18, 2012
NIH Toolbox Scoring and Interpretation Guide September 18, 2012 Jerry Slotkin, PhD Cindy Nowinski, MD, PhD Ron Hays, PhD Jennifer Beaumont, MS James Griffith, PhD Susan Magasi, PhD John Salsman, PhD Richard
More informationAdaptational Approach to Cognitive Rehabilitation in Multiple Sclerosis: Description of Three Models of Care
Adaptational Approach to Cognitive Rehabilitation in Multiple Sclerosis: Description of Three Models of Care Päivi Hämäläinen, PhD; Arja Seinelä, MA; Juhani Ruutiainen, MD Masku Neurological Rehabilitation
More informationNaming Test of the Neuropsychological Assessment Battery: Convergent and Discriminant Validity
Archives of Clinical Neuropsychology 24 (2009) 575 583 Naming Test of the Neuropsychological Assessment Battery: Convergent and Discriminant Validity Brian P. Yochim*, Katherine D. Kane, Anne E. Mueller
More informationBrett Parmenter, PhD, ABPP Kati Pagulayan, PhD VA Puget Sound Healthcare System University of Washington School of Medicine Psychiatry and Behavioral
Brett Parmenter, PhD, ABPP Kati Pagulayan, PhD VA Puget Sound Healthcare System University of Washington School of Medicine Psychiatry and Behavioral Medicine Brett Parmenter, PhD Has no financial interest
More informationTHE INFLUENCE OF CULTURE ON NEUROPSYCHOLOGICAL TESTING IN ZAMBIA
THE INFLUENCE OF CULTURE ON NEUROPSYCHOLOGICAL TESTING IN ZAMBIA BY MARIA ANNA AKANI A thesis submitted to the University of Zambia in fulfilment of the requirements for the degree of Masters in Science
More informationSerial 7s and Alphabet Backwards as Brief Measures of Information Processing Speed
Pergamon Archives of Clinical Neuropsychology, Vol. 11, No. 8, pp. 651-659, 1996 Copyright 9 1996 National Academy of Neuropsychology Printed in the USA. All fights reserved 0887-6177/96 $15.00 +.00 PH
More informationWhole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis Renxin Chu, Shahamat Tauhid, Bonnie I. Glanz, Brian C. Healy, Gloria Kim, Vinit V. Oommen, Fariha
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Godefroy, O., Fickl, A., Roussel, M., Auribault, C., Bugnicourt, J. M., Lamy, C., Petitnicolas, G. (2011). Is the Montreal cognitive assessment superior to the mini-mental
More informationCLINICAL NEUROPSYCHOLOGY PSYC32
University of Toronto at Scarborough Department of Psychology CLINICAL NEUROPSYCHOLOGY PSYC32 Ψ Course Instructor: Zakzanis Lab Instructor: Konstantine Eliyas Jeffay Course Code: PSYC32H3 Lecture: Tuesdays,
More informationReading Based IQ Estimates and Actual Premorbid Cognitive Performance: Discrepancies in a College Athlete Sample
Journal of the International Neuropsychological Society (2012), 18, 139 143. Copyright E INS. Published by Cambridge University Press, 2011. doi:10.1017/s1355617711001275 BRIEF COMMUNICATION Reading Based
More informationOana C. Lindner, Martin G. McCabe, Andrew Mayes, Alison Wearden, Deborah Talmi School of Psychological Sciences University of Manchester
Oana C. Lindner, Martin G. McCabe, Andrew Mayes, Alison Wearden, Deborah Talmi School of Psychological Sciences University of Manchester Background Our preliminary results: Cognitive functioning in pre-treatment
More informationNeuroimaging and Other Biomarkers. MRI for Diagnosis, Prognosis and Treatment Decisions in MS
Neuroimaging and Other Biomarkers MRI for Diagnosis, Prognosis and Treatment Decisions in MS Eric Klawiter, MD MSc Massachusetts General Hospital May 30, 2014 Disclosures and Funding Disclosures: Consulting
More informationCognitive remediation in Recent Onset Schizophrenia: Results of an effectiveness trial
The Brain Dynamics Centre www.brain-dynamics.net Westmead Hospital & University of Sydney Cognitive remediation in Recent Onset Schizophrenia: Results of an effectiveness trial Dr Anthony Harris University
More informationThe Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV
The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV Arianna Perra, P syd, Moira Dux, PhD Terry Lee- Wilk, PhD HIV and HCV in the VA VA is the largest provider
More informationalternate-form reliability The degree to which two or more versions of the same test correlate with one another. In clinical studies in which a given function is going to be tested more than once over
More informationExploration of a weighed cognitive composite score for measuring decline in amnestic MCI
Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI Sarah Monsell NACC biostatistician smonsell@uw.edu October 6, 2012 Background Neuropsychological batteries used
More informationWhat the Clinician Needs to Know about Reviewing the Cognitive Literature. Joshua Sandry, PhD
What the Clinician Needs to Know about Reviewing the Cognitive Literature Joshua Sandry, PhD Neuropsychology & Neuroscience Research Kessler Foundation Department of Physical Medicine & Rehabilitation
More information